Page last updated: 2024-10-21

3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid and Nervous System Diseases

3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid has been researched along with Nervous System Diseases in 2 studies

3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid: structure given in first source; NMDA receptor antagonist

Nervous System Diseases: Diseases of the central and peripheral nervous system. This includes disorders of the brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, autonomic nervous system, neuromuscular junction, and muscle.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kawai, M1
Horikawa, Y1
Ishihara, T1
Shimamoto, K1
Ohfune, Y1
Madsen, U1
Ferkany, JW1
Jones, BE1
Ebert, B1
Johansen, TN1
Holm, T1
Krogsgaard-Larsen, P1

Other Studies

2 other studies available for 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid and Nervous System Diseases

ArticleYear
2-(Carboxycyclopropyl)glycines: binding, neurotoxicity and induction of intracellular free Ca2+ increase.
    European journal of pharmacology, 1992, Feb-11, Volume: 211, Issue:2

    Topics: Amino Acids, Dicarboxylic; Animals; Aspartic Acid; Binding, Competitive; Brain Chemistry; Calcium; C

1992
NMDA receptor agonists derived from ibotenic acid. Preparation, neuroexcitation and neurotoxicity.
    European journal of pharmacology, 1990, Dec-15, Volume: 189, Issue:6

    Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Cerebral Cortex; Choline O-Acetyl

1990